SOLUBLE C-ERBB-2 FRAGMENT IN SERUM CORRELATES WITH DISEASE STAGE AND PREDICTS FOR SHORTENED SURVIVAL IN PATIENTS WITH EARLY-STAGE AND ADVANCED BREAST-CANCER

被引:80
作者
KANDL, H [1 ]
SEYMOUR, L [1 ]
BEZWODA, WR [1 ]
机构
[1] UNIV WITWATERSRAND,SCH MED,DEPT MED,DIV CLI HAEMATOL & MED ONCOL,JOHANNESBURG 2193,SOUTH AFRICA
关键词
D O I
10.1038/bjc.1994.387
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Seventy-nine patients with advanced breast cancer were tested for the presence, in serum, of a 110 kDa soluble, c-erbB-2 fragment. Thirty-nine patients were seropositive. There was no correlation between seropositivity and menopausal status, or with oestrogen status. In addition, no correlation could be found between tissue c-erbB-2 immunostaining for the external domain of the c-erbB-2 receptor and the presence of soluble c-erbB-2 in serum. The presence of serum soluble c-erbB-2, however, had a significant impact on survival of patients with advanced disease, suggesting that this test may become a useful independent prognostic indicator.
引用
收藏
页码:739 / 742
页数:4
相关论文
共 23 条
[1]  
ALLRED DC, 1992, J CLIN ONCOL, V10, P1049
[2]  
BORG A, 1990, CANCER RES, V50, P4332
[3]  
CLARK GM, 1991, CANCER RES, V51, P944
[4]  
CLINE M, 1987, J CLIN ONCOL, V7, P999
[5]  
GUSTERSON BA, 1992, J CLIN ONCOL, V10, P599
[6]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[7]  
LANGTON BC, 1991, CANCER RES, V51, P2593
[8]   ELEVATED SOLUBLE C-ERBB-2 ANTIGEN LEVELS IN THE SERUM AND EFFUSIONS OF A PROPORTION OF BREAST-CANCER PATIENTS [J].
LEITZEL, K ;
TERAMOTO, Y ;
SAMPSON, E ;
MAUCERI, J ;
LANGTON, BC ;
DEMERS, L ;
PODCZASKI, E ;
HARVEY, H ;
SHAMBAUGH, S ;
VOLAS, G ;
WEAVER, S ;
LIPTON, A .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) :1436-1443
[9]  
MAGUIRE HC, 1992, PATHOBIOLOGY, V60, P117
[10]  
MAGUIRE HC, 1989, SEMIN ONCOL, V16, P148